EFFECT OF MIRIKIZUMAB ON INFLAMMATORY BIOMARKERS IN A PHASE 2 STUDY OF PATIENTS WITH CROHN'S DISEASE

Geert R. D'Haens  1     Stefan Schreiber  2     Edouard Louis  3     Bruce E. Sands  4     Elisa Gomez Valderas  5     Debra Miller  6     Noah Agada     April Naegeli     Paul Pollack     Jochen Schmitz     Janneke van der Woude     Jaroslaw KierkuĊ›     William Sandborn    
1 University of Amsterdam Academic Medical Center,Amsterdam,Netherlands
2 Kiel University Institute of Clinical Molecular Biology,Kiel,Germany
3 University Hospital CHU Liege,Liege,Belgium
4 Icahn School of Medicine at Mount Sinai,New York,United States
5 Eli Lilly and Company,Indianapolis,United States
6 Eli Lilly and Company,Indianapolis,U

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing